A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, March 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

blogs: 1 blog
twitter: 5 X users

video: 1 YouTube creator

Citations

dimensions_citation: 159 Dimensions

Readers on

mendeley: 202 Mendeley

Summary Blogs X YouTube Dimensions citations

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 46,737 followers.

RT @Tigerariel40: Reducción de cáncer avanzado de Páncreas con adición de CURCUMINA, un efectivo extractor del Hierro tisular inflamatorio…

24 Apr 2021

Reply Repost Favourite

Reducción de cáncer avanzado de Páncreas con adición de CURCUMINA, un efectivo extractor del Hierro tisular inflamatorio y cancerígeno. https://t.co/dHS1xPL2Hz

24 Apr 2021

Reply Repost Favourite

RT @Immuneadvisors: Theracumin is commercialized curcumin that people actually did #clinicaltrial on But why no efficacy endpoints??? htt…

01 May 2017

Reply Repost Favourite

RT @Immuneadvisors: Theracumin is commercialized curcumin that people actually did #clinicaltrial on But why no efficacy endpoints??? htt…

29 Apr 2017

Reply Repost Favourite

Theracumin is commercialized curcumin that people actually did #clinicaltrial on But why no efficacy endpoints??? https://t.co/nmucnG6qJ0 https://t.co/PWx7L960QB

29 Apr 2017

Reply Repost Favourite

@JackieHill1955 @TumorWarrior @sisteranne @JourneyJoshuas @BenAffleck possble adjunct http://t.co/4DaMXRUX3e http://t.co/L253ZYiZqe

17 Oct 2013

Reply Repost Favourite